Brokers have been very busy this month recommending which ASX 200 shares to buy, hold, and sell.
Three which analysts have given their verdict on are named below. Here’s what they are saying about them:
Beach Energy Ltd (ASX: BPT)
This energy producer’s shares are fully valued according to analysts at Morgans. Given its free cash flow outlook and difficult to analyse results, the broker has downgraded Beach Energy shares from a hold rating to a trim rating with a $1.09 price target. This compares to its current share price of $1.13. It said:
A noisy 1H26 result that was hard to analyse, with the treatment of various items not aligning with what we would expect. Pushing its accounting treatments harder than its operations leaves us concerned around BPT’s forward FCF profile. Gradually declining reserves could suppress BPT’s valuation until it makes an acquisition, a difficult position to be in. We downgrade our rating to TRIM (from HOLD), with an updated A$1.09 target price.
CSL Ltd (ASX: CSL)
The team at Bell Potter hasn’t been overly impressed with recent developments at this biotechnology giant. So, although CSL shares trade at a sizeable discount to historical earnings multiples, it only rates them as a hold with a $175.00 price target. This compares to its current share price of $163.44.
Commenting on the struggling company, the broker said:
CSL now trades on an underlying PE of 16.5x in FY27, well below its historical average but remains above the global biopharma avg of ~15x. It faces the daunting prospect of hiring a new CEO to re-invigorate a lacklustre growth outlook in the face of headwinds on multiple fronts.
Pro Medicus Ltd (ASX: PME)
Morgans is feeling upbeat about this ASX tech stock ahead of the release of its results. In response to the AI-induced software selloff, the broker has upgraded Pro Medicus shares to a buy rating with a $290.00 price target. This implies more than 70% upside for investors from its current share price of $169.47. It said:
PME has been sold off heavily as investors increasingly worry that AI could structurally erode the economics and commoditise premium imaging SaaS platforms. For PME, that feels misunderstood. Bravery required with volatility high and trend weak, but this has proven to be a good time to pick up PME shares. Upgrade to BUY on weakness. 1H26 results due 12th of February.
The post Buy, hold, sell: Beach Energy, CSL, and Pro Medicus shares appeared first on The Motley Fool Australia.
Should you invest $1,000 in Beach Energy Limited right now?
Before you buy Beach Energy Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Beach Energy Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- 5 things to watch on the ASX 200 on Thursday
- What’s Morgans’ view on these ASX shares following earnings results?
- Why ASX, CSL, GQG, and Meteoric Resources shares are sinking today
- CSL shares crash 12% on half-year results and shock CEO exit
- Here’s everything you need to know about CSL’s upcoming dividend
Motley Fool contributor James Mickleboro has positions in CSL and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.